U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H4NO2.Al.2HO.H2O
Molecular Weight 153.0702
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIHYDROXYALUMINUM AMINOACETATE

SMILES

O.[OH-].[OH-].[Al+3].NCC([O-])=O

InChI

InChIKey=UTUUIUQHGDRVPU-UHFFFAOYSA-K
InChI=1S/C2H5NO2.Al.3H2O/c3-1-2(4)5;;;;/h1,3H2,(H,4,5);;3*1H2/q;+3;;;/p-3

HIDE SMILES / InChI

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C2H5NO2
Molecular Weight 75.0666
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Al
Molecular Weight 26.9815386
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

There is not much information related to the medical application of ALUMINIUM TRIGLYCINATE, also known as ALUMINIUM AMINOACETATE. Nevertheless, some articles are describing the antacid properties of this substance and its application in the treatment of peptic ulcer.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Gene expression in primary cultured astrocytes affected by aluminum: alteration of chaperons involved in protein folding.
2011-01
Osteomalacia from Al and Mg antacids. Report of a case of bilateral hip fracture.
1989-06
[Compression force and in-vitro antacid activity of aluminium hydroxide and aluminium glycinate tablets].
1977-11
[Experimental and clinical evaluation of aluminum glycinate, a new intragastric buffer solution for achievement of prolonged physiological pH value].
1955-08-26

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:53:13 GMT 2025
Edited
by admin
on Mon Mar 31 17:53:13 GMT 2025
Record UNII
DO250MG0W6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALUMINIUM GLYCINATE
MART.  
Preferred Name English
DIHYDROXYALUMINUM AMINOACETATE
II   JAN   USP   VANDF  
Systematic Name English
(GLYCINATO)DIHYDROXYALUMINIUM HYDRATE
Common Name English
DIHYDROXYALUMINUM AMINOACETATE [II]
Common Name English
(Glycinato)dihydroxyaluminum hydrate
Common Name English
ALUMINIUM GLYCINATE HYDRATE
Systematic Name English
DIHYDROXYALUMINUM AMINOACETATE [USP MONOGRAPH]
Common Name English
DIHYDROXYALUMINIUM AMINOACETIC ACID
Systematic Name English
Dihydroxyaluminium aminoacetate hydrate [WHO-DD]
Common Name English
ALUMINIUM, (GLYCINATO-N,O)DIHYDROXY-, HYDRATE
Common Name English
ALUMINUM, (GLYCINATO-N,O)DIHYDROXY-, HYDRATE
Common Name English
DIHYDROXYALUMINIUM AMINOACETATE
Systematic Name English
ALUMINIUM GLYCINATE [MART.]
Common Name English
DIHYDROXYALUMINUM AMINOACETIC ACID
Systematic Name English
DIHYDROXYALUMINUM AMINOACETATE [VANDF]
Common Name English
DIHYDROXYALUMINUM AMINOACETATE [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29701
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
CFR 21 CFR 331.15
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
WHO-VATC QA02AB07
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
WHO-ATC A02AB07
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
CFR 21 CFR 331.11
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
Code System Code Type Description
CAS
41354-48-7
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
WIKIPEDIA
ALUMINIUM GLYCINATE
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
RXCUI
23162
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY RxNorm
DRUG CENTRAL
4763
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
PUBCHEM
73415751
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
FDA UNII
DO250MG0W6
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
DRUG BANK
DB13626
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
EVMPD
SUB12823MIG
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
NCI_THESAURUS
C81600
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
MESH
C007420
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
DAILYMED
DO250MG0W6
Created by admin on Mon Mar 31 17:53:13 GMT 2025 , Edited by admin on Mon Mar 31 17:53:13 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE